Skip to main content
OpenTrials
Completed

NCT Number: NCT05633329

Dual Injection ESPB Versus Single Injection ESPB for Laparotomies

To evaluate and compare the efficacy of single level injection erector spinae plane block versus double level injection Erector spinae plane block in laparotomies

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Minia University

Minya, Minya Governorate, 61511, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age18-60.
  • Both genders.
  • abdominal surgery.
  • ASA I-III.

Exclusion criteria

  • Drug allergy.
  • Morbid obesity (BMI >40 kg/m2).
  • Psychiatric disorder.
  • Opiod dependence.
  • patient refuse.

Treatment and study plan

single level

Procedure

injection of 40 ml bupivacaine 0.25 at T8 (20 ml on each side)

dual level

Procedure

injection of 40 ml of bupivacaine 0.25 at two level T7 and T9 (10 ml on each level of both side)

Primary outcomes

  1. first analgesic request

    Time frame: 24 hours

    time to request fentanyl

Secondary outcomes

  1. resting visual analogue pain scale

    Time frame: 24 hours

    pain score at rest from 0-10 which 0 mean no pain and 10 the worst pain

  2. dynamic visual analogue pain scale

    Time frame: 24 hours

    pain score at movement (cough) from 0-10 which 0 mean no pain and 10 the worst pain

  3. analgesic consumption

    Time frame: 24 hours

    total fentanyl required first day postoperative

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Official study title

Comparison Between the Efficacy of Ultrasound Guided Single Injection Erector Spinae Plane Block Versus Dual Injection Erector Spinae Plane Block for Postoperative Pain in Patients Undergoing Abdominal Surgery: Randomized Clinical Study

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Dec 1, 2022
Registry last updated
Jun 22, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.